Product
BR1019C-1
1 clinical trial
2 indications
Indication
HypertensionIndication
Type 2 Diabetes MellitusClinical trial
A Randomized, Double-blind, Multi-center, Phase 3 Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy in Patients With Essential Hypertension and Type 2 Diabetes MellitusStatus: Not yet recruiting, Estimated PCD: 2025-04-01